Aptevo Therapeutics Inc. Operating Lease, Liability, Current
Aptevo Therapeutics Inc. (APVO) had Operating Lease, Liability, Current of $919.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Current $919.00K.
- 2026-03-31: Operating Lease, Liability, Current $892.00K.
- 2025-12-31: Operating Lease, Liability, Current $866.00K.
- 2025-09-30: Operating Lease, Liability, Current $800.00K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $919.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $892.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $866.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $800.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $800.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $800.00K 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $768.00K 10-K · filed 2026-03-26 | $800.00K 10-K · filed 2025-02-14 |
| 2024-09-30 | $700.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $700.00K 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $700.00K 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $700.00K 10-K · filed 2025-02-14 | |
| 2023-09-30 | $700.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $600.00K 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $600.00K 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $400.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $30.00K 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $1.10M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $1.00M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |